Similar Articles
The Effect of Homocysteine Levels on Thrombolytic Treatment in Acute Ischemic Stroke
Ezgi Yılmaz, Elıf Sarıönder Gencer, Ethem Murat Arsava, Mehmet Akif Topcuoğlu
DOI: 10.4274/tnd.2022.48030
Issue: 2022, Volume 28 - Issue 4
308
375
Evaluation of C-reactive Protein/Albumin Ratio According to Stage in Patients with Idiopathic Parkinson Disease
Tamer Yazar, Hülya Olgun Yazar
DOI: 10.4274/tnd.2019.13334
Issue: 2019, Volume 25 - Issue 3
0
326
Frequency of Falls and Relationship Between Falls, Socio-demographic and Clinical Factors in Idiopathic Parkinson’s Disease
Ferhan Soyuer, Feyzan Cankurtaran, Murat Gültekin, Meral Mirza, Gözde Ertürk
DOI: 10.4274/tnd.58855
Issue: 2017, Volume 23 - Issue 1
0
283
The Role of Ceruloplasmin in Neurodegeneration in Parkinson’s Disease
Reyhan Gürer, Şenay Aydın, Dilvin Gökçe, Tunahan Ayaz, Nihal Işık
DOI: 10.4274/tnd.58751
Issue: 2016, Volume 22 - Issue 1
0
285
Plasma Homocystein, Vitamin B12, Folate, Protein C And S Levels in Stroke Population At Acute Stage
M. Fazıl GENÇ, Sibel KARŞIDAĞ, Feriha ÖZER, Yasemin DÖVENTAŞ, Macit KOLDAŞ
Issue: 2003, Volume 9 - Issue 1
0
276
The Role of Hyperhomocysteinemia in İschemic Stroke
Şeref DEMİRKAYA, Okay VURAL, Ahmet AYDIN, Zeki GÖKÇİL, M. Akif TOPÇUOĞLU, Aşkın IŞIMER
Issue: 1999, Volume 5 - Issue 2
0
258